These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). II. Background of patients]. Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H. Jpn J Antibiot; 1995 Oct; 48(10):1422-35. PubMed ID: 8544338 [Abstract] [Full Text] [Related]
43. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina. Uzunovic-Kamberovic S. J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214 [Abstract] [Full Text] [Related]
44. Epidemiology of urinary tract infection and antimicrobial resistance in a pediatric hospital in Nepal. Ganesh R, Shrestha D, Bhattachan B, Rai G. BMC Infect Dis; 2019 May 14; 19(1):420. PubMed ID: 31088380 [Abstract] [Full Text] [Related]
49. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Wasfi R, Abd El-Rahman OA, Mansour LE, Hanora AS, Hashem AM, Ashour MS. Indian J Med Microbiol; 2012 May 14; 30(1):76-80. PubMed ID: 22361765 [Abstract] [Full Text] [Related]
51. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R. Med Princ Pract; 2004 May 14; 13(6):334-9. PubMed ID: 15467308 [Abstract] [Full Text] [Related]
52. [Chemobiotic sensitivity of common Gram-negative bacteria in urinary tract infections, 1981-1982]. Mastandrea P, Delli Carri P. Quad Sclavo Diagn; 1983 Dec 14; 19(4):455-62. PubMed ID: 6377362 [Abstract] [Full Text] [Related]
53. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, Grosjean P, Talarmin A. J Antimicrob Chemother; 2007 Feb 14; 59(2):309-12. PubMed ID: 17138569 [Abstract] [Full Text] [Related]
54. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection. Akhter T, Baqai R, Aziz M. Pak J Pharm Sci; 2010 Jan 14; 23(1):108-13. PubMed ID: 20067876 [Abstract] [Full Text] [Related]
55. Antimicrobial resistance patterns of uropathogens among children in Istanbul, Turkey. Ipek IO, Bozaykut A, Arman DC, Sezer RG. Southeast Asian J Trop Med Public Health; 2011 Mar 14; 42(2):355-62. PubMed ID: 21710858 [Abstract] [Full Text] [Related]
56. [Statistical studies on bacteria isolated from urinary tract infections (report 4)]. Okada K, Nakajima N, Kawashima T, Miyakita H, Nishizawa K, Shiramizu M, Nagata Y, Katsuoka Y, Kinoshita H, Kawamura N. Hinyokika Kiyo; 1987 Jul 14; 33(7):1080-91. PubMed ID: 3687632 [Abstract] [Full Text] [Related]
57. High rates of quinolone resistance among urinary tract infections in the ED. Khawcharoenporn T, Vasoo S, Ward E, Singh K. Am J Emerg Med; 2012 Jan 14; 30(1):68-74. PubMed ID: 21075586 [Abstract] [Full Text] [Related]
58. Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. Dada-Adegbola HO, Muili KA. Afr J Med Med Sci; 2010 Sep 14; 39(3):173-9. PubMed ID: 21416786 [Abstract] [Full Text] [Related]
59. Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens. Scarparo C, Piccoli P, Ricordi P, Scagnelli M. Eur J Clin Microbiol Infect Dis; 2002 Apr 14; 21(4):283-9. PubMed ID: 12072939 [Abstract] [Full Text] [Related]
60. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species. Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F. Chemioterapia; 1988 Oct 14; 7(5):287-91. PubMed ID: 3224396 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]